$150 Million M&A Loan Closes! Shanghai Bank Empowers Healthcare Tech Companies' Cross-Border Integration

Recently, a $150 million cross-border M&A loan issued by Shanghai Bank was successfully finalized. It not only strongly promoted the strategic integration of local high-tech medical device companies Yimai Medical and Wobi Medical; but also, through the coordinated “M&A loan + investment fund” model, helped Wobi complete a major debt restructuring and capital structure optimization, paving the way for its overseas listing.

This cross-border M&A loan not only demonstrates Shanghai Bank’s responsibility as a state-owned financial enterprise in implementing national policies to further improve overseas comprehensive service systems and expand financing channels for outbound companies, but also marks a strategic upgrade of Shanghai Bank’s tech financial service model from single credit lending to an innovative ecosystem empowered by a “financial partner” approach.

坚持长期主义，甘当“耐心资金”陪伴科企穿越周期

Wobi Medical was founded in 2015, as a global innovative medical company focused on stroke treatment technology. Shanghai Bank provided credit support early in the company’s development, accompanying it through its peak moments of rapid expansion in the European and American markets.

However, the path of technological innovation is full of twists and turns. Since 2023, with changes in the external environment, Wobi Medical has faced valuation corrections and tightening financing in the medical device industry, along with complex internal debt challenges. Some financial institutions have chosen to reduce exposure.

“Based on in-depth analysis of the neurointervention track and ongoing tracking of the company’s core technological innovation and overseas market expansion, we chose to ‘go against the trend’ by increasing credit support, becoming Wobi Medical’s largest credit provider during industry fluctuations,” said Zhong Xiaofeng, project leader at Shanghai Bank.

Shanghai Bank deeply understands that tech companies need more than just funding—they require comprehensive resource support. Therefore, while helping Wobi Medical address operational funding needs, the bank also proactively collaborates with the company to explore ways to shed historical debt burdens and achieve healthy development. It continuously connects with investment institutions, shareholders, and management teams to jointly plan for a “spring” of growth.

创新银基协同，以创投思维赋能跨境并购重组

As external capital markets recover and the Hong Kong biotech and pharmaceutical sector revives, Shanghai Bank keenly seized the opportunity for the company’s development turnaround.

Based on long-term tracking of the company’s performance and in-depth industry research, Shanghai Bank recognized that Wobi Medical, one of the few domestic neurointerventional device companies with most revenue from high-end markets like Europe and America, possesses significant technological, global platform, and strategic value. Together with its shareholders, the bank devised an innovative “M&A loan + investment fund” plan.

Unlike full equity acquisition by a fund, this plan offers relatively low-cost bank leverage, helping the company resolve debt issues, optimize its capital structure, and structure the M&A transaction to provide more operational funds for its global expansion. However, because the target involved multiple jurisdictions, dispersed shareholders, and an extremely complex structure, some investment funds were cautious about the feasibility of bank involvement. Ultimately, Shanghai Bank relied on its strong professional capabilities to deliver a swift solution.

“Having experienced this restructuring firsthand, I am deeply moved by Shanghai Bank’s professionalism, efficiency, and human touch. They are brave in innovation, willing to provide timely support, and help companies grow at critical moments. I believe this compassionate and responsible financial power of Shanghai Bank will continue to empower more local enterprises to grow steadily and far,” said Yu Jie, CFO of Wobi Medical.

全周期金融陪伴，构建科技金融服务新范式

The issuance of this M&A loan is not the end of service, but a new beginning of Shanghai Bank’s full lifecycle financial companionship for the company. Moving forward, the bank will leverage the efficiency and low exchange costs of its FT account cross-border settlement system to help Wobi Medical optimize global working capital management; and, adhering to the “investment-loan linkage” approach, continue to support the company’s next round of financing and IPO process with comprehensive financial services.

Technological innovation is a national strategic asset, and financial empowerment is key. Shanghai Bank elevates tech finance to a strategic level, adhering to long-term and professional principles, and is actively using financial innovation to cultivate new productive forces and promote a healthy “technology-industry-finance” cycle with strong financial momentum. In the future, the bank will replicate and promote this bank-enterprise synergy model, building a full-chain service ecosystem of “fundraising, investment, management, and exit” to meet the full lifecycle financial needs of innovative and invested companies. By providing “financing + intelligence” integrated financial services, it aims to achieve strategic win-win with tech startups and investment funds, jointly writing new chapters of technological innovation and industrial upgrading, and becoming a “financial partner with passion, value, talent, and respect.”